291 related articles for article (PubMed ID: 19689312)
1. Cell transplantation: a future therapy for narcolepsy?
Arias-Carrión O; Murillo-Rodríguez E
CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):309-14. PubMed ID: 19689312
[TBL] [Abstract][Full Text] [Related]
2. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
4. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat.
Gerashchenko D; Kohls MD; Greco M; Waleh NS; Salin-Pascual R; Kilduff TS; Lappi DA; Shiromani PJ
J Neurosci; 2001 Sep; 21(18):7273-83. PubMed ID: 11549737
[TBL] [Abstract][Full Text] [Related]
5. [Hypocretin system and narcolepsy].
Arias-Carrión O
Rev Med Chil; 2009 Sep; 137(9):1209-16. PubMed ID: 20011964
[TBL] [Abstract][Full Text] [Related]
6. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
[TBL] [Abstract][Full Text] [Related]
7. Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta.
Gerashchenko D; Salin-Pascual R; Shiromani PJ
Brain Res; 2001 Sep; 913(1):106-15. PubMed ID: 11532254
[TBL] [Abstract][Full Text] [Related]
8. Narcolepsy: new understanding of irresistible sleep.
Krahn LE; Black JL; Silber MH
Mayo Clin Proc; 2001 Feb; 76(2):185-94. PubMed ID: 11213307
[TBL] [Abstract][Full Text] [Related]
9. Hypocretin ligand deficiency in narcolepsy: recent basic and clinical insights.
Ritchie C; Okuro M; Kanbayashi T; Nishino S
Curr Neurol Neurosci Rep; 2010 May; 10(3):180-9. PubMed ID: 20425033
[TBL] [Abstract][Full Text] [Related]
10. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.
Chemelli RM; Willie JT; Sinton CM; Elmquist JK; Scammell T; Lee C; Richardson JA; Williams SC; Xiong Y; Kisanuki Y; Fitch TE; Nakazato M; Hammer RE; Saper CB; Yanagisawa M
Cell; 1999 Aug; 98(4):437-51. PubMed ID: 10481909
[TBL] [Abstract][Full Text] [Related]
11. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
Beuckmann CT; Yanagisawa M
J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
[TBL] [Abstract][Full Text] [Related]
12. Effects of hypocretin/orexin cell transplantation on narcoleptic-like sleep behavior in rats.
Arias-Carrión O; Murillo-Rodríguez E
PLoS One; 2014; 9(4):e95342. PubMed ID: 24736646
[TBL] [Abstract][Full Text] [Related]
13. The hypocretin/orexin system in health and disease.
Nishino S
Biol Psychiatry; 2003 Jul; 54(2):87-95. PubMed ID: 12873797
[TBL] [Abstract][Full Text] [Related]
14. Animal models of narcolepsy.
Chen L; Brown RE; McKenna JT; McCarley RW
CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):296-308. PubMed ID: 19689311
[TBL] [Abstract][Full Text] [Related]
15. Hypocretin/orexin and narcolepsy: new basic and clinical insights.
Nishino S; Okuro M; Kotorii N; Anegawa E; Ishimaru Y; Matsumura M; Kanbayashi T
Acta Physiol (Oxf); 2010 Mar; 198(3):209-22. PubMed ID: 19555382
[TBL] [Abstract][Full Text] [Related]
16. Integrative physiology of orexins and orexin receptors.
Mieda M; Sakurai T
CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):281-95. PubMed ID: 19689310
[TBL] [Abstract][Full Text] [Related]
17. The hypocretins and their role in narcolepsy.
Kroeger D; de Lecea L
CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):271-80. PubMed ID: 19689309
[TBL] [Abstract][Full Text] [Related]
18. The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.
Arias-Carrión O; Bradbury M
CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):232-4. PubMed ID: 19689304
[TBL] [Abstract][Full Text] [Related]
19. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice.
Liu M; Thankachan S; Kaur S; Begum S; Blanco-Centurion C; Sakurai T; Yanagisawa M; Neve R; Shiromani PJ
Eur J Neurosci; 2008 Oct; 28(7):1382-93. PubMed ID: 18973565
[TBL] [Abstract][Full Text] [Related]
20. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.
Mieda M; Willie JT; Hara J; Sinton CM; Sakurai T; Yanagisawa M
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4649-54. PubMed ID: 15070772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
